Fund V surpassed its $150 million target to reach the $200 million hard cap, with the continued support from many long-time limited partners as well as new participation from several large national and international institutions.
EndoChoice has been named as one of “Atlanta’s Best and Brightest Companies to Work For™”, a designation that hundreds of companies pursue. EndoChoice was identified as a company that delivers exceptional human resource practices as measured by the National Association for Business Resources.
River Cities’ Glen Mayfield, along with several other Cincinnati business leaders, visits Israel to meet with venture firms and exciting companies.
The Christ Hospital Health Network announces the appointment of Rob Heimann to its Board of Directors.
Greater Miami Chamber of Commerce recognizes local company for its exemplary business performance and contribution to the community.
Former Geomagic CEO, Steve Carnevale will now serve as Chief Operating Officer for StepLeader, bringing more than 27 years of experience in financial management, business analysis, strategic planning and operational controls.
Fuse™ Colonoscopy dramatically outperforms standard forward-viewing colonoscopes.
Collins brings formidable business leadership experience to advisory role at Ifbyphone, supporting the company’s accelerated growth plans.
The landscape of medical device investing is as competitive as ever before – putting pressure on companies to present stellar, “better, faster, cheaper” solutions. River Cities’ Rik Vandevenne offers eight qualities that investors are looking for in potential portfolio companies to ensure that you’re putting your best foot forward when presenting to these ever-vigilant investment teams.
Mr. Scott Davis, the Chairman and CEO of UPS (NYSE: UPS) and Mr. Scott Huennekens, President and CEO of Volcano Corporation (NASDAQ: VOLC) have joined the board as EndoChoice looks to more than double its revenue in 2014.